首页> 外国专利> RETINOIC ACID RECEPTOR GAMMA (RARG) GENE POLYMORPHISMS PREDICTIVE OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY (ACT)

RETINOIC ACID RECEPTOR GAMMA (RARG) GENE POLYMORPHISMS PREDICTIVE OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY (ACT)

机译:维甲酸受体γ(RARG)基因多态性预测蒽环类药物引起的心血管疾病(ACT)

摘要

Provided are methods for assessing the susceptibility of a subject to thedevelopment ofcardiotoxicity in response to receiving one or more anthracycline compounds,the methodincluding determining the presence or absence of one or more polymorphisms,wherein thepresence or absence of one or more such polymorphisms is indicative ofsusceptibility to thedevelopment of cardiotoxicity.
机译:提供了用于评估受试者对皮肤的敏感性的方法。发展接受一种或多种蒽环类化合物引起的心脏毒性,方法包括确定一种或多种多态性的存在与否,其中是否存在一种或多种这种多态性表明易感性心脏毒性的发展。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号